Purus Wealth Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-12,186
Closed -$288K – 121
2023
Q1
$288K Sell
12,186
-154
-1% -$3.54K 0.23% 87
2022
Q4
$269K Sell
12,340
-22
-0.2% -$543 0.24% 89
2022
Q3
$302K Sell
12,362
-128
-1% -$3.54K 0.28% 77
2022
Q2
$335K Sell
12,490
-31
-0.2% -$997 0.3% 71
2022
Q1
$489K Sell
12,521
-27
-0.2% -$1.05K 0.34% 69
2021
Q4
$575K Buy
12,548
+6,930
+123% +$331K 0.36% 65
2021
Q3
$266K Buy
5,618
+168
+3% +$7.85K 0.18% 81
2021
Q2
$253K Buy
5,450
+100
+2% +$4.53K 0.18% 73
2021
Q1
$235K Buy
5,350
+76
+1% +$3.45K 0.2% 68
2020
Q4
$216K Buy
+5,274
New +$206K 0.19% 67

Other funds holding FFTY

Purus Wealth Management's FFTY Position: Q2 2023 in Review

Purus Wealth Management sold out of CapForce IBD 50 ETF (FFTY) in Q2 2023, closing a stake of 12,186 shares — an estimated $288K sold.

Purus Wealth Management first reported a position in FFTY in Q4 2020 and held it in 10 quarters. The position peaked at $575K in Q4 2021. 45 funds tracked by Wall St. Rank hold FFTY as of Q2 2023.

  • Purus Wealth Management reported no remaining CapForce IBD 50 ETF position as of Q2 2023 after selling out during the quarter.
  • Purus Wealth Management sold 12,186 CapForce IBD 50 ETF shares in Q2 2023, an estimated $288K.
  • Purus Wealth Management first reported a position in CapForce IBD 50 ETF in Q4 2020 and held it in 10 quarters.
  • Purus Wealth Management's CapForce IBD 50 ETF position peaked at $575K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2023.

Based on Purus Wealth Management's 13F filing for Q2 2023, filed 21 Jul 2023.